Buzz: A buyer is in talks to acquire a big stake in Celltrion

John Carroll The buzz about the potential sale of a big stake in Celltrion, Korea's biosimilars developer, picked up after the company filed a statement with regulators indicating ...

Aratana adds pet therapies in $38M deal to acquire Vet

John Carroll Aratana Therapeutics has struck a deal to buy San Diego-based Vet Therapeutics, adding new pet therapies to its pipeline for $ 30 million in cash, a chunk of stock, a ...

Capsugel to Acquire Bend Research

barbara.lempert MORRISTOWN, N.J. and BEND, Ore. – September 5, 2013 – Capsugel and Bend Research announced today that they have entered into a definitive agreement for Capsugel ...

Otsuka Pharmaceutical to Acquire Astex Pharmaceuticals for $866M

barbara.lempert TOKYO–(BUSINESS WIRE)–Otsuka Pharmaceutical Co., Ltd. is pleased to announce an agreement with Astex Pharmaceuticals, Inc. (“Astex”) to acquire ...

Quintiles to Acquire Novella Clinical

barbara.lempert Acquisition bolsters Quintiles’ small biopharma, oncology and medical device capabilities RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–To stay ...

Actelion enters into an agreement to acquire privately-held Ceptaris Therapeutics

barbara.lempert VALCHLOR(TM) gel under FDA Review for Early-Stage Mycosis Fungoides-Type CTCL ALLSCHWIL/BASEL, SWITZERLAND and MALVERN, PA – 31 July 2013 – Actelion US ...

MTPC to Acquire Medicago for $357 Million

mia.burns Medicago announces agreement to be acquired by Mitsubishi Tanabe Pharma in a transaction valued at $ 357M   QUÉBEC CITY, July 12, 2013 /PRNewswire/ – Medicago ...

Buyout buzz: Royalty might mount joint effort to acquire Elan

Ryan McBride In the latest twist in Royalty Pharma's plot to buy Elan, the business press has caught wind that Royalty may decide to revive its pursuit of Elan with the help and ...

Bellus Health to Acquire Thallion Pharmaceuticals

barbara.lempert LAVAL, QC, June 18, 2013 – BELLUS Health Inc. (TSX: BLU) (“BELLUS Health”) and Thallion Pharmaceuticals Inc. (“Thallion”) (TSXV: TLN) ...

J&J to Acquire Aragon Pharmaceuticals for Close to $1B

barbara.lempert Johnson & Johnson Announces Definitive Agreement To Acquire Aragon Pharmaceuticals, Inc. Late-Stage Prostate Cancer Treatment Strengthens Oncology Pipeline NEW ...

OPKO Health to acquire Prolor Biotech for $480M

Emily Mullin OPKO Health ($ OPK) announced today that it is poised to acquire Israel-based Prolor Biotech in an all-stock transaction valued at $ 480 million, or $ 7 per ...
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS